Journey Medical Corp. (DERM)
6.25
-0.08
(-1.26%)
USD |
NASDAQ |
May 18, 15:19
Journey Medical EPS Diluted (Quarterly) : -0.0817 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Assertio Holdings, Inc. | -2.931 |
| Zevra Therapeutics, Inc. | 0.603 |
| Aquestive Therapeutics, Inc. | -0.0657 |
| Corcept Therapeutics, Inc. | -0.2988 |
| Johnson & Johnson | 2.141 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.23M |
| Revenue (Quarterly) | 15.96M |
| Total Expenses (Quarterly) | 18.19M |
| Enterprise Value | 172.54M |
| Gross Profit Margin (Quarterly) | 53.99% |
| Profit Margin (Quarterly) | -13.97% |
| Earnings Yield | -6.13% |
| Normalized Earnings Yield | -6.133 |